These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Real-time tracking of neighborhood surroundings and mood in urban drug misusers: application of a new method to study behavior in its geographical context. Epstein DH; Tyburski M; Craig IM; Phillips KA; Jobes ML; Vahabzadeh M; Mezghanni M; Lin JL; Furr-Holden CDM; Preston KL Drug Alcohol Depend; 2014 Jan; 134():22-29. PubMed ID: 24332365 [TBL] [Abstract][Full Text] [Related]
23. Trajectories of craving during medication-assisted treatment for opioid-use disorder: Subtyping for early identification of higher risk. Burgess-Hull AJ; Panlilio LV; Preston KL; Epstein DH Drug Alcohol Depend; 2022 Apr; 233():109362. PubMed ID: 35217274 [TBL] [Abstract][Full Text] [Related]
24. Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use. Epstein DH; Willner-Reid J; Vahabzadeh M; Mezghanni M; Lin JL; Preston KL Arch Gen Psychiatry; 2009 Jan; 66(1):88-94. PubMed ID: 19124692 [TBL] [Abstract][Full Text] [Related]
25. Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients. Huhn AS; Sweeney MM; Brooner RK; Kidorf MS; Tompkins DA; Ayaz H; Dunn KE Neuropsychopharmacology; 2019 Mar; 44(4):826-833. PubMed ID: 30375498 [TBL] [Abstract][Full Text] [Related]
26. Effects of Prereactivation Propranolol on Cocaine Craving Elicited by Imagery Script/Cue Sets in Opioid-dependent Polydrug Users: A Randomized Study. Jobes ML; Aharonovich E; Epstein DH; Phillips KA; Reamer D; Anderson M; Preston KL J Addict Med; 2015; 9(6):491-8. PubMed ID: 26501788 [TBL] [Abstract][Full Text] [Related]
27. Effect of Acupuncture for Methadone Reduction : A Randomized Clinical Trial. Lu L; Chen C; Chen Y; Dong Y; Chen R; Wei X; Tao C; Li C; Wang Y; Fan B; Tang X; Xu S; He Z; Mo G; Liu Y; Gu H; Li X; Cao F; Xu H; Zhang Y; Li G; Liu X; Zeng J; Tang C; Xu N Ann Intern Med; 2024 Aug; 177(8):1039-1047. PubMed ID: 38976882 [TBL] [Abstract][Full Text] [Related]
28. Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances. Serre F; Fatseas M; Denis C; Swendsen J; Auriacombe M Addict Behav; 2018 Aug; 83():123-129. PubMed ID: 29428330 [TBL] [Abstract][Full Text] [Related]
29. Single high-dose buprenorphine for opioid craving during withdrawal. Ahmadi J; Jahromi MS; Ghahremani D; London ED Trials; 2018 Dec; 19(1):675. PubMed ID: 30526648 [TBL] [Abstract][Full Text] [Related]
30. Tobacco, cocaine, and heroin: Craving and use during daily life. Epstein DH; Marrone GF; Heishman SJ; Schmittner J; Preston KL Addict Behav; 2010 Apr; 35(4):318-24. PubMed ID: 19939575 [TBL] [Abstract][Full Text] [Related]
31. Activity space during treatment with medication for opioid use disorder: Relationships with personality, mood, and drug use. Panlilio LV; Burgess-Hull AJ; Feldman JD; Rogers JM; Tyburski M; Smith KE; Epstein DH J Subst Use Addict Treat; 2024 Feb; 157():209219. PubMed ID: 37981240 [TBL] [Abstract][Full Text] [Related]
32. The association of pain impact and sleep disruption with opioid withdrawal during opioid-use disorder treatment. Ellis JD; Han D; Mayo J; Hobelmann JG; Finan PH; Huhn AS Br J Clin Pharmacol; 2024 Jun; 90(6):1408-1417. PubMed ID: 38417973 [TBL] [Abstract][Full Text] [Related]
33. Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy. Bertz JW; Epstein DH; Reamer D; Kowalczyk WJ; Phillips KA; Kennedy AP; Jobes ML; Ward G; Plitnick BA; Figueiro MG; Rea MS; Preston KL J Subst Abuse Treat; 2019 Nov; 106():43-57. PubMed ID: 31540611 [TBL] [Abstract][Full Text] [Related]
34. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial. Falcato L; Beck T; Reimer J; Verthein U J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130 [TBL] [Abstract][Full Text] [Related]
35. Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients. Arout CA; Waters AJ; MacLean RR; Compton P; Sofuoglu M Psychopharmacology (Berl); 2019 Oct; 236(10):2857-2866. PubMed ID: 30564869 [TBL] [Abstract][Full Text] [Related]
36. Stress and opioid use disorder: A systematic review. MacLean RR; Armstrong JL; Sofuoglu M Addict Behav; 2019 Nov; 98():106010. PubMed ID: 31238237 [TBL] [Abstract][Full Text] [Related]
37. Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence. Huhn AS; Harris J; Cleveland HH; Lydon DM; Stankoski D; Cleveland MJ; Deneke E; Bunce SC Brain Res Bull; 2016 May; 123():94-101. PubMed ID: 26876756 [TBL] [Abstract][Full Text] [Related]
38. Cocaine craving and use during daily life. Preston KL; Vahabzadeh M; Schmittner J; Lin JL; Gorelick DA; Epstein DH Psychopharmacology (Berl); 2009 Dec; 207(2):291-301. PubMed ID: 19777216 [TBL] [Abstract][Full Text] [Related]
39. Short term health-related quality of life improvement during opioid agonist treatment. Nosyk B; Bray JW; Wittenberg E; Aden B; Eggman AA; Weiss RD; Potter J; Ang A; Hser YI; Ling W; Schackman BR Drug Alcohol Depend; 2015 Dec; 157():121-8. PubMed ID: 26511766 [TBL] [Abstract][Full Text] [Related]
40. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use. Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]